Fact sheet -Updated November 2015
Advocacy report March 2011
303100 03/2011 E 1,000
Global Plan to end TB 2016-2020
For Children and their Families
October 2015
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Informe sobre poblaciones clave
Accessed November 2017
Informe sobre poplaciones clave.
END TB
Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas.
Accessded December 2017
Experience of national TB partnerships
People Who Inject Drugs
In addition, the following individuals of our external expert advisory committee made instrumental contributions to the initial design and content of the document: Billy Pick, USAID; Daniel Wolfe, Open Society Foundations; Dave Burrows, AIDS Projects Management Group; Fabi...enne Hariga, United Nations Office on Drugs and Crime; Mauro Guarinieri, the Global Fund to Fight AIDS, Tuberculosis and Malaria; Richard Needle, Office of the U.S. Global AIDS Coordinator; and Sergey Votyagov, EHRN.
more
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Technical information note. Ensuring an uninterrupted supply of quality-assured, affordable anti-TB
drugs and diagnostics to the world